Drug Topics September 24, 2025
In part 3 of our interview with Rae McMahan, she explores her role at Prescryptive Health and how she’s helping pharmacy stakeholders navigate complex GLP-1 prescription drug benefits.
Amid the rise in popularity and constant discussions surrounding glucagon-like peptide-1 (GLP-1) medications, many stakeholders in the pharmacy industry have attempted to navigate significant complexities within this drug class. Whether it’s the patients taking them, the pharmacists dispensing them, or the pharmacy benefit managers (PBMs) determining coverage, the challenges and hurdles of GLP-1 benefits highlight a larger issue within the pharmacy industry.
“I don’t know the last time that we’ve seen a drug in market that provides this level of clinical value, where there’s not just one drug in market, there’s a...







